ArticleFrontiers in pharmacology2018

Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Fang-Hong Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.